Nano Flow’s NT-proBNP (AA 13-27) gold conjugate is based on a monoclonal antibody targeting the N-terminal pro-brain natriuretic peptide (NT-proBNP), a key cardiac biomarker used in the diagnosis and monitoring of heart failure. Validated as a detection antibody in lateral flow assays, this conjugate ensures reliable and sensitive performance in cardiac diagnostics. The corresponding capture antibody is also available, offering developers a complete pair solution for assay development.
NT-proBNP (AA 13-27) Gold Conjugate – 40 nm (Ref NF-NTproBNP-AU)
Produced on Nano Flow’s highly spherical 40 nm gold nanoparticles (OD20), this conjugate provides excellent reproducibility, stability, and clear visual signal intensity, making it an ideal choice for rapid cardiac diagnostic assays.
Applications: Lateral flow assays (LF) and other immunoassay formats.
Certificate of Analysis: Supplied for each batch, including TEM, DLS, and UV-Vis characterization.
Technical Specifications
| Parameter | Specification |
|---|---|
| Antibody format | IgG1 |
| Host | Mouse |
| Clonality | Monoclonal |
| Specificity | NT-proBNP, amino acids 13–27 (38-43, 61-76, 39-76 available upon request) |
| Cross-reactivity | None reported |
| Gold nanoparticle size | 40 nm |
| Concentration of the gold conjugate | OD20 |
| Buffer | Borate, BSA 0.25%, NaN₃ 0.09%, pH 7.3 |
| Shelf life | 1 year |
| Available volumes | From 1 ml to 1 L+ |
